PZ Cormay S.A.

CRM

PLCMRAY00029

Medical Equipment, Supplies & Distribution

Market Closed - Warsaw S.E. Other stock markets 11:55:52 2024-05-31 EDT			5-day change	1st Jan Change
0.606 ^PLN	-0.33%		-0.66%	+3.06%

05-17	PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	PZ Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PZ Cormay S.A. announced that it has received PLN 7 million in funding

October 10, 2018

On October 11, 2018, PZ Cormay S.A. (WSE:CRM) closed the transaction.

Latest news about PZ Cormay S.A.

PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-17	CI
PZ Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-15	CI
PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-19	CI
PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-09	CI
PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-20	CI
PZ Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Pz Cormay S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-09-10	CI
Pz Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-23	CI
PZ Cormay S.A. acquired unknown minority stake in Orphée SA for CHF 1.2 million.	20-11-16	CI
Pz Cormay S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
PZ Cormay S.A. completed the acquisition of 0.54% stake in Orphée SA for PLN 0.37 million.	20-02-05	CI
PZ Cormay S.A. made a tender offer to acquire remaining 2.9% stake in Orphée SA for PLN 2 million.	19-12-10	CI
PZ Cormay S.A. agreed to acquire remaining 11.6% stake in Orphée SA for PLN 7.8 million.	19-09-04	CI
PZ Cormay S.A. announced that it has received PLN 7 million in funding	18-10-10	CI
PZ Cormay S.A. announced that it expects to receive PLN 7 million in funding	18-08-06	CI
Cormay Seeks To Divest	17-12-16	CI
PZ Cormay S.A. cancelled the acquisition of an additional 12.95% stake in Orphée SA from TTL 1 SP Z O O.	17-05-17	CI
Wesolowski To Reportedly Acquire PZ Cormay	16-06-24	CI
PZ Cormay S.A. signed an agreement to acquire additional 12.95% stake in Orphée SA from TTL 1 SP Z O O for PLN 10 million.	16-05-17	CI
PZ Cormay S.A. announced that it has received funding from Ipopema Towarzystwo Funduszy Inwestycyjnych S.A..	15-09-28	CI
TTL 1 SP Z O O and another shareholder completed the acquisition of 27% stake in Orphée SA from PZ Cormay S.A..	15-03-03	CI

PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
PZ CORMAY S.A.	+3.06%	12.98M
BIOMÉRIEUX	-3.43%	12.1B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.17%	8.24B
LANTHEUS HOLDINGS, INC.	+31.98%	5.58B
AUTOBIO DIAGNOSTICS CO., LTD.	-10.03%	4.15B
10X GENOMICS, INC.	-59.94%	2.68B
ANDON HEALTH CO., LTD.	+11.23%	2.63B
VITROLIFE AB	-5.14%	2.24B
MYRIAD GENETICS, INC.	+18.91%	2.03B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-7.56%	1.79B